Showing results (21-30 of 129) with videos related to

Sort By:
Pageof 13
Molecular Cancer|June 9, 2017
Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumorsNetta Mäkinen, Kati Kämpjärvi, Norma Frizzell, et al.
Acta Obstetricia Et Gynecologica Scandinavica|December 15, 2015
Incidence of and risk factors for surgical site infections in women undergoing hysterectomy for endometrial carcinomaTaru Tuomi, Annukka Pasanen, Arto Leminen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2014
Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinomaAnna Luomaranta, Jouko Lohi, Ralf Bützow, et al.
Gynecologic Oncology|November 3, 2011
Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinomaNina Linder, Ralf Bützow, Heini Lassus, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 13, 2017
Prediction of Site-Specific Tumor Relapses in Patients With Stage I-II Endometrioid Endometrial CancerTaru Tuomi, Annukka Pasanen, Arto Leminen, et al.
Scientific Reports|December 13, 2022
Interpretable prognostic modeling of endometrial cancerBulat Zagidullin, Annukka Pasanen, Mikko Loukovaara, et al.
International Journal of Cancer|August 6, 2013
Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomasNetta Mäkinen, Pia Vahteristo, Ralf Bützow, et al.
Pageof 13